Cloverfields Capital Group, LP Novo Nordisk A S Transaction History

Cloverfields Capital Group, LP

  • $281 Million
  • Q3 2024

A detailed history of Cloverfields Capital Group, LP transactions in Novo Nordisk A S stock. As of the latest transaction made, Cloverfields Capital Group, LP holds 22,976 shares of NVO stock, worth $2.38 Million. This represents 0.97% of its overall portfolio holdings.

Number of Shares
22,976
Previous 26,749 14.11%
Holding current value
$2.38 Million
Previous $3.82 Million 28.37%
% of portfolio
0.97%
Previous 1.38%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$119.07 - $145.42 $449,251 - $548,669
-3,773 Reduced 14.11%
22,976 $2.74 Million
Q2 2024

Aug 13, 2024
BUY
$122.71 - $146.91 $29,327 - $35,111
239 Added 0.9%
26,749 $3.82 Million
Q1 2024

May 14, 2024
BUY
$102.11 - $135.92 $28,897 - $38,465
283 Added 1.08%
26,510 $3.4 Million
Q4 2023

Feb 12, 2024
SELL
$87.78 - $105.45 $184,250 - $221,339
-2,099 Reduced 7.41%
26,227 $2.71 Million
Q3 2023

Nov 14, 2023
BUY
$90.94 - $199.54 $1.29 Million - $2.83 Million
14,163 Added 100.0%
28,326 $2.58 Million
Q2 2023

Aug 14, 2023
BUY
$155.98 - $172.65 $1.52 Million - $1.68 Million
9,738 Added 220.07%
14,163 $2.29 Million
Q1 2023

Sep 07, 2023
SELL
$132.34 - $159.14 $664,876 - $799,519
-5,024 Reduced 35.47%
9,139 $1.45 Million
Q1 2023

May 12, 2023
SELL
$132.34 - $159.14 $101,240 - $121,742
-765 Reduced 14.74%
4,425 $704,000
Q4 2022

Feb 14, 2023
SELL
$102.55 - $135.33 $325,288 - $429,266
-3,172 Reduced 37.93%
5,190 $702,000
Q3 2022

Nov 14, 2022
BUY
$95.28 - $116.93 $6,669 - $8,185
70 Added 0.84%
8,362 $833,000
Q2 2022

Aug 12, 2022
SELL
$103.24 - $121.81 $14,969 - $17,662
-145 Reduced 1.72%
8,292 $924,000
Q1 2022

May 12, 2022
SELL
$93.1 - $112.54 $191,879 - $231,944
-2,061 Reduced 19.63%
8,437 $937,000
Q3 2021

Nov 12, 2021
BUY
$84.42 - $106.62 $6,162 - $7,783
73 Added 0.7%
10,498 $1.01 Million
Q2 2021

Aug 12, 2021
BUY
$67.66 - $84.76 $8,592 - $10,764
127 Added 1.23%
10,425 $873,000
Q1 2021

May 13, 2021
BUY
$67.06 - $75.82 $10,193 - $11,524
152 Added 1.5%
10,298 $694,000
Q4 2020

Feb 16, 2021
BUY
$63.89 - $73.8 $648,227 - $748,774
10,146 New
10,146 $709,000

Others Institutions Holding NVO

# of Institutions
1,957
Shares Held
320M
Call Options Held
5.49M
Put Options Held
7.78M
View Full List

About NOVO NORDISK A S

NVO Quotes by TradingView
  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $233B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Cloverfields Capital Group, LP Portfolio

Follow Cloverfields Capital Group, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cloverfields Capital Group, LP, based on Form 13F filings with the SEC.

News

Stay updated on Cloverfields Capital Group, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email